This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignees: Baxter Healthcare Sa, Baxter International Inc.. Active years: 2013-2015.
Company Filing History:
2 out of 1,198 
2 out of 2,530 
Years Active: 2013-2015
Title: Innovations of Isabelle Catelas
Introduction
Isabelle Catelas is a notable inventor based in Ottawa, Canada. She has made significant contributions to the field of medical technology, particularly in the development of fibrin sealants. With a total of 2 patents, her work focuses on therapeutic applications that address various health conditions.
Latest Patents
Isabelle's latest patents include the invention of a fibrin gel for controlled release of platelet-derived growth factor (PDGF). This innovative product is designed for therapeutic applications, including treatment for musculoskeletal disorders, soft tissue disorders, and vascular diseases. The fibrin sealants she has developed are aimed at providing effective solutions for these medical challenges.
Career Highlights
Throughout her career, Isabelle has worked with prominent companies such as Baxter Healthcare and Baxter International Inc. Her experience in these organizations has allowed her to refine her skills and contribute to groundbreaking advancements in medical technology.
Collaborations
Isabelle has collaborated with talented professionals in her field, including Shane Donovan and Wanda Seyton. These partnerships have further enhanced her innovative capabilities and have led to successful projects in the medical sector.
Conclusion
Isabelle Catelas is a distinguished inventor whose work in fibrin sealants has the potential to transform therapeutic applications in medicine. Her contributions are paving the way for advancements that can significantly improve patient care and treatment outcomes.